Skip to main content
Erschienen in: Psychiatric Quarterly 4/2014

01.12.2014 | Original Paper

Seasonality, Smoking and History of Poor Treatment Compliance are Strong Predictors of Dropout in a Naturalistic 6 Year Follow-Up of Bipolar Patients

verfasst von: Elena Ezquiaga, Aurelio García-López, Consuelo de Dios, Jose Luis Agud, David Albillo, Lorena Vega-Piris

Erschienen in: Psychiatric Quarterly | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Bipolar disorder is a highly recurrent disease which requires long-term treatment. Dropout is a major problem, poorly understood. The objectives of this study were to know the risk of dropout of a cohort of bipolar patients under ambulatory treatment and to identify the clinical profile of patients more likely to abandon the follow-up. A sample of 285 BD I and II patients was followed up for a mean of 2.87 years. A significant proportion of patients failed regular follow-up. The dropout rates were 6.3 % at three months, 12.7 % at 6 months, and 17.6, 27.2, 37.3, 44.0, 47.2 and 49.0 % at 1, 2, 3, 4, 5 and 6 years respectively. Very few variables at baseline predicted dropout. Patients under 35 years of age were more likely to dropout than older cases. Seasonality, smoking and specially history of poor treatment compliance were strong predictors of dropout. Given the magnitude of dropout, additional early clinical interventions should be considered for high-risk patients.
Literatur
1.
Zurück zum Zitat Judd LL, Akiskal HS, Schettler PJ, et al.: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59(6):530–537,2002.PubMedCrossRef Judd LL, Akiskal HS, Schettler PJ, et al.: The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59(6):530–537,2002.PubMedCrossRef
2.
Zurück zum Zitat Connelly CE, Davenport YB, Nurnberger JI Jr: Adherence to treatment regimen in a lithium carbonate clinic. Archives of General Psychiatry 39(5):585–588, 1982.PubMedCrossRef Connelly CE, Davenport YB, Nurnberger JI Jr: Adherence to treatment regimen in a lithium carbonate clinic. Archives of General Psychiatry 39(5):585–588, 1982.PubMedCrossRef
3.
Zurück zum Zitat Suppes T, Baldessarini RJ, Faedda GL, et al.: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 48(12):1082–088, 1991.PubMedCrossRef Suppes T, Baldessarini RJ, Faedda GL, et al.: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 48(12):1082–088, 1991.PubMedCrossRef
4.
Zurück zum Zitat Sajatovic M, Valenstein M, Blow FC, et al.: Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders 8(3):232–241, 2006.PubMedCrossRef Sajatovic M, Valenstein M, Blow FC, et al.: Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disorders 8(3):232–241, 2006.PubMedCrossRef
5.
Zurück zum Zitat Altman S, Haeri S, Cohen LJ, et al.: Predictors of relapse in bipolar disorder: A review. Journal of Psychiatric Practice 12(5):269–282, 2006.PubMedCrossRef Altman S, Haeri S, Cohen LJ, et al.: Predictors of relapse in bipolar disorder: A review. Journal of Psychiatric Practice 12(5):269–282, 2006.PubMedCrossRef
6.
Zurück zum Zitat Gaudiano BA, Weinstock LM, Miller IW: Improving treatment adherence in bipolar disorder: A review of current psychosocial treatment efficacy and recommendations for future treatment development. Behaviour Modification 32(3):267–301, 2008.CrossRef Gaudiano BA, Weinstock LM, Miller IW: Improving treatment adherence in bipolar disorder: A review of current psychosocial treatment efficacy and recommendations for future treatment development. Behaviour Modification 32(3):267–301, 2008.CrossRef
7.
Zurück zum Zitat Martinez-Aran A, Scott J, Colom F, et al.: Treatment nonadherence and neurocognitive impairment in bipolar disorder. Journal of Clinical Psychiatry 70(7):1017–1023, 2009.PubMedCrossRef Martinez-Aran A, Scott J, Colom F, et al.: Treatment nonadherence and neurocognitive impairment in bipolar disorder. Journal of Clinical Psychiatry 70(7):1017–1023, 2009.PubMedCrossRef
8.
Zurück zum Zitat Berk L, Hallam KT, Colom F, et al.: Enhancing medication adherence in patients with bipolar disorder. Human Psychopharmacology 25(1):1–16, 2010.PubMedCrossRef Berk L, Hallam KT, Colom F, et al.: Enhancing medication adherence in patients with bipolar disorder. Human Psychopharmacology 25(1):1–16, 2010.PubMedCrossRef
9.
Zurück zum Zitat Gutierrez-Rojas L, Jurado D, Martinez-Ortega JM, et al.: Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample. Journal of Affective Disorder 127(1–3):77–83, 2010.CrossRef Gutierrez-Rojas L, Jurado D, Martinez-Ortega JM, et al.: Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample. Journal of Affective Disorder 127(1–3):77–83, 2010.CrossRef
10.
Zurück zum Zitat Kane JM, Kishimoto T, Correll CU: Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 12(3):216–26, 2013.PubMedCentralPubMedCrossRef Kane JM, Kishimoto T, Correll CU: Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 12(3):216–26, 2013.PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Leclerc E, Mansur RB, Brietzke E: Determinants of adherence to treatment in bipolar disorder: A comprehensive review. Journal of Affective Disorder 149(1–3):247–252, 2013.CrossRef Leclerc E, Mansur RB, Brietzke E: Determinants of adherence to treatment in bipolar disorder: A comprehensive review. Journal of Affective Disorder 149(1–3):247–252, 2013.CrossRef
12.
Zurück zum Zitat Keck PE Jr, McElroy SL, Strakowski SM, et al.: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. American Journal of Psychiatry 155(5):646–652, 1998.PubMed Keck PE Jr, McElroy SL, Strakowski SM, et al.: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. American Journal of Psychiatry 155(5):646–652, 1998.PubMed
13.
Zurück zum Zitat Colom F, Vieta E, Tacchi MJ, et al.: Identifying and improving non-adherence in bipolar disorders. Bipolar Disorders 79(Suppl 5):24–31,2005.PubMedCrossRef Colom F, Vieta E, Tacchi MJ, et al.: Identifying and improving non-adherence in bipolar disorders. Bipolar Disorders 79(Suppl 5):24–31,2005.PubMedCrossRef
14.
Zurück zum Zitat Busby KK, Sajatovic M: REVIEW: Patient, treatment, and systems-level factors in bipolar disorder nonadherence: A summary of the literature. CNS Neuroscience and Therapeutics 16(5):308–315,2010.PubMedCrossRef Busby KK, Sajatovic M: REVIEW: Patient, treatment, and systems-level factors in bipolar disorder nonadherence: A summary of the literature. CNS Neuroscience and Therapeutics 16(5):308–315,2010.PubMedCrossRef
15.
Zurück zum Zitat Miller R, Ream G, McCormack J, et al.: A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophrenia Research 113(2–3):138–144,2009.PubMedCentralPubMedCrossRef Miller R, Ream G, McCormack J, et al.: A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophrenia Research 113(2–3):138–144,2009.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Olfson M, Mojtabai R, Sampson NA, et al.: Dropout from outpatient mental health care in the United States. Psychiatric Services 60(7):898–907, 2009.PubMedCentralPubMedCrossRef Olfson M, Mojtabai R, Sampson NA, et al.: Dropout from outpatient mental health care in the United States. Psychiatric Services 60(7):898–907, 2009.PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Wells JE, Browne MO, Aguilar-Gaxiola S, et al.: Drop out from out-patient mental healthcare in the World Health Organization’s World Mental Health Survey initiative. British Journal of Psychiatry 202:42–49, 2013.PubMedCrossRef Wells JE, Browne MO, Aguilar-Gaxiola S, et al.: Drop out from out-patient mental healthcare in the World Health Organization’s World Mental Health Survey initiative. British Journal of Psychiatry 202:42–49, 2013.PubMedCrossRef
18.
Zurück zum Zitat Schneck CD, Miklowitz DJ, Miyahara S, et al.: The prospective course of rapid-cycling bipolar disorder: Findings from the STEP-BD [quiz 410]. American Journal of Psychiatry 165(3):370-377, 2008. Schneck CD, Miklowitz DJ, Miyahara S, et al.: The prospective course of rapid-cycling bipolar disorder: Findings from the STEP-BD [quiz 410]. American Journal of Psychiatry 165(3):370-377, 2008.
19.
Zurück zum Zitat Mazza M, Mandelli L, Di Nicola M, et al.: Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. Journal of Affective Disorders 115(1–2):27–35, 2009.PubMedCrossRef Mazza M, Mandelli L, Di Nicola M, et al.: Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. Journal of Affective Disorders 115(1–2):27–35, 2009.PubMedCrossRef
20.
Zurück zum Zitat Moon E, Chang JS, Kim MY, et al.: Dropout rate and associated factors in patients with bipolar disorders. Journal of Affective Disorders, 2012. Moon E, Chang JS, Kim MY, et al.: Dropout rate and associated factors in patients with bipolar disorders. Journal of Affective Disorders, 2012.
21.
Zurück zum Zitat De Dios C, Ezquiaga E, Garcia A, et al.: Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: A prospective, 18-month follow-up study. Journal of Affective Disorders 125(1–3):74–81, 2010.PubMedCrossRef De Dios C, Ezquiaga E, Garcia A, et al.: Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: A prospective, 18-month follow-up study. Journal of Affective Disorders 125(1–3):74–81, 2010.PubMedCrossRef
22.
Zurück zum Zitat De Dios C, Agud JL, Ezquiaga E, et al.: Syndromal and subsyndromal illness status and five-year morbidity using criteria of the International Society for Bipolar Disorders compared to alternative criteria. Psychopathology 45(2):102–108, 2012.PubMedCrossRef De Dios C, Agud JL, Ezquiaga E, et al.: Syndromal and subsyndromal illness status and five-year morbidity using criteria of the International Society for Bipolar Disorders compared to alternative criteria. Psychopathology 45(2):102–108, 2012.PubMedCrossRef
23.
Zurück zum Zitat Garcia-Lopez A, Ezquiaga E, de Dios C, et al.: Retraso diagnóstico y diferencias por sexo y subtipo clínico en una cohorte de pacientes ambulatorios con trastorno bipolar. Rev Psiquiat Salud Ment 3(3):79–89, 2010.PubMedCrossRef Garcia-Lopez A, Ezquiaga E, de Dios C, et al.: Retraso diagnóstico y diferencias por sexo y subtipo clínico en una cohorte de pacientes ambulatorios con trastorno bipolar. Rev Psiquiat Salud Ment 3(3):79–89, 2010.PubMedCrossRef
24.
Zurück zum Zitat Sheehan DV, Lecrubier Y, Sheehan KH, et al.: The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 [quiz 34–57]. Journal of Clinical Psychiatry 59(Suppl 20):22–33, 1998. Sheehan DV, Lecrubier Y, Sheehan KH, et al.: The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 [quiz 34–57]. Journal of Clinical Psychiatry 59(Suppl 20):22–33, 1998.
25.
Zurück zum Zitat Colom F, Vieta E, Daban C, et al.: Clinical and therapeutic implications of predominant polarity in bipolar disorder. Journal of Affective Disorders 93(1–3):13–17, 2006.PubMedCrossRef Colom F, Vieta E, Daban C, et al.: Clinical and therapeutic implications of predominant polarity in bipolar disorder. Journal of Affective Disorders 93(1–3):13–17, 2006.PubMedCrossRef
26.
Zurück zum Zitat Ramos-Brieva JA, Cordero Villafafila A: Validación de la versión española de la Escala de Hamilton para la Depresión. Actas Luso Esp Neurol Psiquiatr Cienc Afines 14(4):324–334, 1986.PubMed Ramos-Brieva JA, Cordero Villafafila A: Validación de la versión española de la Escala de Hamilton para la Depresión. Actas Luso Esp Neurol Psiquiatr Cienc Afines 14(4):324–334, 1986.PubMed
27.
Zurück zum Zitat Colom F, Vieta E, Martinez-Aran A, et al.: [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. Medicina Clinica (Barcelona) 119(10):366–371, 2002.CrossRef Colom F, Vieta E, Martinez-Aran A, et al.: [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. Medicina Clinica (Barcelona) 119(10):366–371, 2002.CrossRef
28.
Zurück zum Zitat Vieta E, Torrent C, Martinez-Aran A, et al.: [A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M]. Actas Espanolas de Psiquiatria 30(5):301–304, 2002. Vieta E, Torrent C, Martinez-Aran A, et al.: [A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M]. Actas Espanolas de Psiquiatria 30(5):301–304, 2002.
29.
Zurück zum Zitat Colom F, Vieta E, Martinez-Aran A, et al.: Clinical factors associated with treatment noncompliance in euthymic bipolar patients. Journal of Clinical Psychiatry 61(8):549–555, 2000.PubMedCrossRef Colom F, Vieta E, Martinez-Aran A, et al.: Clinical factors associated with treatment noncompliance in euthymic bipolar patients. Journal of Clinical Psychiatry 61(8):549–555, 2000.PubMedCrossRef
30.
Zurück zum Zitat StataCorp LP (Ed): Stata Statistical Software: Resease 11, College Station Tx, 2009. StataCorp LP (Ed): Stata Statistical Software: Resease 11, College Station Tx, 2009.
31.
Zurück zum Zitat McCarthy JF, Blow FC, Valenstein M, et al.: Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers. Health Services Research 42(3 Pt 1):1042–1060, 2007.PubMedCentralPubMedCrossRef McCarthy JF, Blow FC, Valenstein M, et al.: Veterans Affairs Health System and mental health treatment retention among patients with serious mental illness: evaluating accessibility and availability barriers. Health Services Research 42(3 Pt 1):1042–1060, 2007.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Simon GE, Ludman EJ, Bauer MS, et al.: Long-term effectiveness and cost of a systematic care program for bipolar disorder. Archives General Psychiatry 63(5):500–508, 2006.PubMedCrossRef Simon GE, Ludman EJ, Bauer MS, et al.: Long-term effectiveness and cost of a systematic care program for bipolar disorder. Archives General Psychiatry 63(5):500–508, 2006.PubMedCrossRef
33.
Zurück zum Zitat Goikolea JM, Colom F, Martinez-Aran A, et al.: Clinical and prognostic implications of seasonal pattern in bipolar disorder: A 10-year follow-up of 302 patients. Psychological Medicine 37(11):1595–1599, 2007.PubMedCrossRef Goikolea JM, Colom F, Martinez-Aran A, et al.: Clinical and prognostic implications of seasonal pattern in bipolar disorder: A 10-year follow-up of 302 patients. Psychological Medicine 37(11):1595–1599, 2007.PubMedCrossRef
34.
Zurück zum Zitat Geoffroy PA, Bellivier F, Scott J, et al.: Bipolar disorder with seasonal pattern: Clinical characteristics and gender influences. Chronobiology International, 2013. Geoffroy PA, Bellivier F, Scott J, et al.: Bipolar disorder with seasonal pattern: Clinical characteristics and gender influences. Chronobiology International, 2013.
35.
Zurück zum Zitat Gonzalez-Pinto A, Gutierrez M, Ezcurra J, et al.: Tobacco smoking and bipolar disorder. Journal of Clinical Psychiatry 59(5):225–228, 1998.PubMedCrossRef Gonzalez-Pinto A, Gutierrez M, Ezcurra J, et al.: Tobacco smoking and bipolar disorder. Journal of Clinical Psychiatry 59(5):225–228, 1998.PubMedCrossRef
36.
Zurück zum Zitat Waxmonsky JA, Thomas MR, Miklowitz DJ, et al.: Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program. General Hospital Psychiatry 27(5):321–328, 2005.PubMedCrossRef Waxmonsky JA, Thomas MR, Miklowitz DJ, et al.: Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program. General Hospital Psychiatry 27(5):321–328, 2005.PubMedCrossRef
37.
Zurück zum Zitat Berk M, Ng F, Wang WV, et al.: Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. Journal of Affective Disorders 110(1–2):126–134, 2008.CrossRef Berk M, Ng F, Wang WV, et al.: Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania. Journal of Affective Disorders 110(1–2):126–134, 2008.CrossRef
38.
Zurück zum Zitat Dodd S, Brnabic AJ, Berk L, et al.: A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Comprehensive Psychiatry 51(5):504–509, 2010.PubMedCrossRef Dodd S, Brnabic AJ, Berk L, et al.: A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder. Comprehensive Psychiatry 51(5):504–509, 2010.PubMedCrossRef
39.
Zurück zum Zitat Baek JH, Eisner LR, Nierenberg AA: Smoking and suicidality in subjects with bipolar disorder: results from the national epidemiologic survey on alcohol and related conditions (nesarc). Depression and Anxiety 30(10):982–990, 2013.PubMed Baek JH, Eisner LR, Nierenberg AA: Smoking and suicidality in subjects with bipolar disorder: results from the national epidemiologic survey on alcohol and related conditions (nesarc). Depression and Anxiety 30(10):982–990, 2013.PubMed
40.
Zurück zum Zitat Moylan S, Jacka FN, Pasco JA, et al.: How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: A critical review of biological pathways. Brain and Behavior 3(3):302–306, 2013.PubMedCentralPubMedCrossRef Moylan S, Jacka FN, Pasco JA, et al.: How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: A critical review of biological pathways. Brain and Behavior 3(3):302–306, 2013.PubMedCentralPubMedCrossRef
41.
42.
Zurück zum Zitat Garcia-Portilla MP, Saiz PA, Benabarre A, et al.: Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica 121(6):437–445, 2010. Garcia-Portilla MP, Saiz PA, Benabarre A, et al.: Impact of substance use on the physical health of patients with bipolar disorder. Acta Psychiatrica Scandinavica 121(6):437–445, 2010.
43.
Zurück zum Zitat Aagaard J, Vestergaard P, Maarbjerg K: Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry 21(4):166–170, 1988.PubMedCrossRef Aagaard J, Vestergaard P, Maarbjerg K: Adherence to lithium prophylaxis: II. Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry 21(4):166–170, 1988.PubMedCrossRef
44.
Zurück zum Zitat Graff FS, Griffin ML, Weiss RD: Predictors of dropout from group therapy among patients with bipolar and substance use disorders. Drug and Alcohol Dependence 94, (1–3):272–275, 2008.PubMedCentralPubMedCrossRef Graff FS, Griffin ML, Weiss RD: Predictors of dropout from group therapy among patients with bipolar and substance use disorders. Drug and Alcohol Dependence 94, (1–3):272–275, 2008.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Scott J, Pope M: Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. American Journal of Psychiatry 159(11):1927–1929, 2002.PubMedCrossRef Scott J, Pope M: Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. American Journal of Psychiatry 159(11):1927–1929, 2002.PubMedCrossRef
46.
Zurück zum Zitat Ascher-Svanum H, Zhu B, Faries D, et al.: A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. Journal of Clinical Psychiatry 67(7):1114–1123, 2006.PubMedCrossRef Ascher-Svanum H, Zhu B, Faries D, et al.: A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. Journal of Clinical Psychiatry 67(7):1114–1123, 2006.PubMedCrossRef
47.
Zurück zum Zitat Vestergaard P, Schou M: Prospective studies on a lithium cohort. 1. General features. Acta Psychiatrica Scandinavica 78(4):421–426, 1988.PubMedCrossRef Vestergaard P, Schou M: Prospective studies on a lithium cohort. 1. General features. Acta Psychiatrica Scandinavica 78(4):421–426, 1988.PubMedCrossRef
48.
Zurück zum Zitat Eker F, Harkin S: Effectiveness of six-week psychoeducation program on adherence of patients with bipolar affective disorder. Journal of Affective Disorders 138(3):409–416, 2012.PubMedCrossRef Eker F, Harkin S: Effectiveness of six-week psychoeducation program on adherence of patients with bipolar affective disorder. Journal of Affective Disorders 138(3):409–416, 2012.PubMedCrossRef
49.
Zurück zum Zitat Rosa AR, Marco M, Fachel JM, et al.: Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31(1):217–224, 2007.PubMedCrossRef Rosa AR, Marco M, Fachel JM, et al.: Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry 31(1):217–224, 2007.PubMedCrossRef
Metadaten
Titel
Seasonality, Smoking and History of Poor Treatment Compliance are Strong Predictors of Dropout in a Naturalistic 6 Year Follow-Up of Bipolar Patients
verfasst von
Elena Ezquiaga
Aurelio García-López
Consuelo de Dios
Jose Luis Agud
David Albillo
Lorena Vega-Piris
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 4/2014
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-014-9303-9

Weitere Artikel der Ausgabe 4/2014

Psychiatric Quarterly 4/2014 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.